Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study
Crossref DOI link: https://doi.org/10.1007/s12282-017-0815-7
Published Online: 2017-11-20
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hattori, Masaya
Ishiguro, Hiroshi
Masuda, Norikazu
Yoshimura, Akiyo
Ohtani, Shoichiro
Yasojima, Hiroyuki
Morita, Satoshi
Ohno, Shinji
Iwata, Hiroji
License valid from 2017-11-20